ProstaLund

Second quarter

April 1 - June 30

• Net sales reached SEK 2,8 (5,3) million
• Operating profit/loss totaled SEK -7,2 million (-4,0) million
• Loss after taxes SEK -7,2 (-4,1) million
• Earnings per share, SEK (basic and diluted) amounted to SEK -0,09 (-0,07)
• Cash flow from operating activities amounted to SEK -6,6 (-0,5) million

January 1 - June 30

• Net sales reached SEK 6,3 (10,9) million
• Operating profit/loss totaled SEK -11,9 million (-7,2) million
• Loss after taxes SEK -12,0 (-7,3) million
• Earnings per share, SEK (basic and diluted) amounted to SEK -0,16 (-0,12)
• Cash flow from operating activities amounted to SEK -12,7 (-6,0) million
• Cash and cash equivalents amounted to SEK 3,4 (34,1) million as per June 30, 2024

Significant events during the period

• Two new studies with ProstaLund’s Schelin Catheter® presented at the EAU in Paris on April 8
• Positive results from unannounced inspection by TÜV SÜD, regarding our regulatory authorisations conducted on April 9-10
• ProstaLund and Capio Specialistcenter AB signed on Aprill 22 a new agre- ement regarding disposable materials used in CoreTherm® treatments. The agreement is over 12 months, with an option to extend. The order value is approximately SEK 1,3 million over the contract period. The agreement repla- ces the previous agreement with Capio Specialistcenter AB
• ProstaLund decided on May 20 that the Board of Directors intends to decide on a rights issue of units for an initial issue amount of around 29 MSEK
• The preliminary investigation towards the former Chairman and major share- holders of the Company was closed on May 23
• ProstaLund received a certificate with MDR and ISO13485 from TÜV SÜD on May 27
• The communique from the annual general meeting was published on May 30
• New agreement signed on May 31st regarding CoreTherm® treatments in Austria
• Bridge loan amounting to 4 MSEK was signed with the main owner on June 10
• New agreement signed on June 24 regarding CoreTherm® treatments in Arhus, Denmark
• The outcome of the rights issue was published on June 28. Around 80 per- cent or SEK 23 million was reached before deduction of the costs related to the transaction

Significant events after the end of the period

• ProstaLund informed on July 3rd that a direct issue of units instead of cash compensation to one Guarantor will be performed in connection with the right issue
• ProstaLund informed on July 11 that it will announce the last day of trading in BTUs after the rights issue has been registered.
• ProstaLund informed on July 17 the last day of trading in BTUs and the first day of trading in warrants of series TO 3.

Key figures

”With a new organisation in place, we are moving full speed ahead!”

Anders Kristensson
CEO, ProstaLund AB (publ)

Please see attached PDF for full report.